TARS Tarsus Pharmaceuticals reports 1467 percent Q4 2025 revenue growth but wider than expected EPS losses push shares 16 percent lower CDNS Cadence tops Q4 2025 earnings estimates posts 141 percent year over year revenue growth as shares climb 236 percent CACI Intl CACI Stock Why It Could Break Down RangeBound 20260420 Diamondback Energy FANG YTD Outperformance Relative to Broader OilsEnergy Peer Group Analysis ADT Inc ADT Stock Key Levels and Trend Analysis Q4 2025 EPS Exceeds Expectations Artelo ARTL Stock Short Interest Analysis Smart Money Flows 20260420 iShares iBoxx High Yield Corporate Bond ETF HYG Steady Income and Capital Gains in a Supportive Credit Environment TRTNB Triton 8 preferred shares offer steady income as investors weigh fixedincome appeal amid market volatility Is Calamos CSQ Still a Buy After 177 Rally 20260520 BRC Group RILYP Earnings Outlook Key Metrics for Q1 2024